BP Directors, LP is 10% Owner at Lantern Pharma Inc. (LTRN). They have made 6 open-market trades across 2 companies since 2022, most recently 2025-06-13.
CIK 0001813311
1 open-market purchase totalling $4.0M since 2024, against 5 sales. Too few scored purchases to measure a record yet.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 40% | 60% | 40% |
| Avg Move | +9.2% | +21.3% | +17.3% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| LTRN | SELL | 2025-06-13 | 2025-06-13 | $3.09 | $124K | +1.3% | +28.7% | +26.8% |
| ACTU | BUY | 2024-08-14 | 2024-08-14 | $8.00 | $4.0M | -19.6% | -19.1% | -8.9% |
| ACTU | SELL | 2024-08-14 | 2024-08-14 | $9.00 | $225K | -19.6% | -19.1% | -8.9% |
| LTRN | SELL | 2024-02-27 | 2024-02-29 | $4.68 | $600K | +60.1% | +97.7% | +24.9% |
| LTRN | SELL | 2024-01-17 | 2024-01-19 | $4.20 | $472K | +5.2% | -0.5% | +43.9% |
| LTRN | SELL | 2022-09-02 | 2022-09-07 | $5.20 | $34K | -0.8% | -0.2% | -0.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.